Institutional Ownership
Boston Scientific Corp
CUSIP 101137107COMBSXQ1 2026
Latest EPS (Diluted)
$0.90
Q1 2026 · Mar 31, 2026
Latest Revenue
$5.20B
Reported quarter
Latest Net Income
—
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.90 | $0.90 | $5.20B | — | 10-Q |
| Sep 30, 2025 | Q3 2025 | $0.51 | $0.51 | $5.07B | — | 10-Q |
| Jun 30, 2025 | Q2 2025 | $0.54 | $0.53 | $5.06B | — | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.46 | $0.45 | $4.66B | — | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.32 | $0.32 | $4.21B | — | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.22 | $0.22 | $4.12B | — | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.34 | $0.33 | $3.86B | — | 10-Q |
| Sep 30, 2023 | Q3 2023 | $0.34 | $0.34 | $3.53B | — | 10-Q |
| Jun 30, 2023 | Q2 2023 | $0.18 | $0.18 | $3.60B | — | 10-Q |
| Mar 31, 2023 | Q1 2023 | $0.21 | $0.21 | $3.39B | — | 10-Q |
| Sep 30, 2022 | Q3 2022 | $0.12 | $0.12 | $3.17B | — | 10-Q |
| Jun 30, 2022 | Q2 2022 | $0.17 | $0.17 | $3.24B | — | 10-Q |